Novo Nordisk (NVO) Stock Gains as Wegovy Drug Gets FDA Nod for Liver Disease

Shares of Danish pharmaceutical company Novo Nordisk (NVO) rose on Friday after the U.S. Food and Drug Administration (FDA) granted accelerated approval for Wegovy to treat metabolic-associated steatohepatitis (MASH) in adults with moderate to advanc... [2397 chars]